Outlook Therapeutics, Inc.
OTLK
Revenue
1.51M
▼-4.35M▼-74.28%
69 Months ChangeAssets
22.39M
▲3.32M▲17.39%
3 Months ChangeLiabilities
59.58M
▲8.04M▲15.61%
3 Months ChangeFree Cash Flow
-10.02M
▼-271.59k▼-2.79%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-14
Form 10-Q
ID: 0001558370-24-012234
2024-08-14
Form 8-K
ID: 0001104659-24-089325
2024-07-08
Form 8-K
ID: 0001104659-24-078207
2024-05-28
Form 8-K
ID: 0001104659-24-065609
2024-05-15
Form 8-K
ID: 0001104659-24-062054
2024-05-15
Form 10-Q
ID: 0001558370-24-008318
2024-05-13
Form 8-K
ID: 0001104659-24-060517
2024-05-01
Form 8-K
ID: 0001104659-24-055141
2024-04-15
Form 8-K
ID: 0001104659-24-047322
2024-04-12
Form 8-K
ID: 0001104659-24-046752